PharmNovaTechBridge

PharmNovaTechBridge is a venture builder that co-creates, co-invests in and commercially develops health-science companies in pharma, biotech and One Health (human and veterinary) across Central and Eastern Europe. Its services include scouting and developing pharmaceutical assets, venture creation, commercial acceleration through licensing and partnership deals, and scientific asset evaluation.

The company describes its customers as established CEE health-science companies seeking access to Western markets, and VC funds, private equity firms and family offices that need scientific and commercial due diligence on regional opportunities. It also works with universities, startups and industry partners, and states that it takes equity in the ventures it builds. Its CBRN segment is described as serving defense and government stakeholders.

The company is registered as PharmNovaTechBridge s.r.o. in the Czech Republic, founded in 2024, with Praha as its registered headquarters city. The website lists 6 ongoing pharma projects, 5 veterinary projects and 3 CBRN research projects, and names Kristian Lorenc (CEO and co-founder) and Kamil Kuca (CSO and co-founder). Open roles listed on the careers page include Senior Project Manager, Associate Director Drug Delivery and Data Scientist, IT, with San Francisco, CA given as the location.

Product: Venture building and commercial acceleration services for pharma, biotech and One Health companies, including asset scouting, licensing deal structuring and scientific due diligence.